Amendment 0004 issued since this procurement is using the procedures of 41 U.S.C. 1901, as implemented by Class Deviation 2026-O0028 – Revolutionary Federal Acquisition Regulation (FAR) Overhaul Part ... Amendment 0004 issued since this procurement is using the procedures of 41 U.S.C. 1901, as implemented by Class Deviation 2026-O0028 – Revolutionary Federal Acquisition Regulation (FAR) Overhaul Part 12, Defense FAR Supplement (DFARS) Part 212 and Revolutionary FAR Overhaul Part 12.201-1. See updated Ondansetron ODT Solicitation attached.

Amendment 0003 issued to extend the closing date to April 22, 2026 at 3:00 PM EST.

Amendment 0002 issued to extend the closing date to 3/23/2026 at 3:00 PM EST.

Amendment 0001 issued to allow for Bottles and / or Blister Packaging to be offered in response to this solicitation.

The Defense Logistics Agency is planning a national requirements contract for Ondansetron Orally Disintegrating Tablets in 4MG and 8MG doses. It will be a firm-fixed price contract with a one-year base period and four one-year option periods. The contract will establish a national supply source for several federal agencies. The projected solicitation date is September 2025, though the agency reserves the right to issue it before or after that date. This is an unrestricted, fully competitive acquisition for a commercial item.